Medications
Novartis drug investigated after 11 deaths
A multiple sclerosis drug made by industry giant Novartis is under investigation after at least 11 patients taking the medicine died.
Jan 20, 2012
0
0
Page 28 - News tagged with heart drug
Medications
Studies provide latest 'real world' evidence on effectiveness of COVID-19 treatments
Two studies published by The BMJ today provide up to date evidence on the effectiveness of both currently licensed and possible COVID-19 treatments under everyday ("real world") conditions, helping to shed more light on whether ...
Nov 16, 2022
0
6
Cardiology
Not faster, but longer -- new drug changes beat in treating heart failure
A new drug which offers a radically different approach to treating certain types of heart failure has been shown to improve cardiac function in heart failure patients in its first clinical trials.
Aug 19, 2011
0
0
Cardiology
New approach to tackling uncontrolled high blood pressure shows significant results
Scientists from Queen Mary University of London and Barts Health NHS Trust have successfully improved blood pressure control among patients with severe intolerance to antihypertensive medication - by using medicines in unconventional ...
Aug 26, 2015
0
64
Cardiology
US approves first heart pump for children
The US Food and Drug Administration has approved a first mechanical cardiac assist device for children that can help keep patients alive as they await a transplant.
Dec 18, 2011
0
0
Medications
US regulators give limited approval to cholesterol drug
US regulators on Friday approved a new cholesterol drug called Praluent, made by Sanofi and Regeneron, for people with certain genetic risk factors for heart disease.
Jul 25, 2015
0
10
Medical research
MRIs could become powerful tools for monitoring cholesteral therapy
MRI scanning could become a powerful new tool for assessing how well cholesterol drugs are working, according to Loyola University Health System cardiologist Binh An P. Phan, MD.
Oct 14, 2011
2
0
Diabetes
Amylin's long-delayed diabetes drug gets FDA nod
Amylin Pharmaceuticals won approval Friday for its long-delayed diabetes drug Bydureon, a next-generation treatment that requires fewer injections than the company's 7-year old diabetes medicine, Byetta.
Jan 28, 2012
0
0
Medical research
Blood pressure drugs may offer benefits in valvular heart disease
Drugs used to treat blood pressure could offer significant benefits to patients with one of the most common forms of valvular heart disease, new research at the University of Dundee and NHS Tayside has revealed.
Aug 1, 2011
0
0
Medications
FDA panel to weigh revoking key use of Abbott drug
(AP) -- A panel of advisers to the Food and Drug Administration will consider this week whether to revoke a key indication from Abbott's blockbuster cholesterol drug Trilipix.
May 17, 2011
0
0
